Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 13
2004 11
2005 16
2006 7
2007 11
2008 11
2009 7
2010 7
2011 10
2012 5
2013 9
2014 6
2015 13
2016 19
2017 13
2018 14
2019 14
2020 16
2021 36
2022 21
2023 31
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Results by year

Filters applied: . Clear all
Page 1
G-quadruplexes: a promising target for cancer therapy.
Kosiol N, Juranek S, Brossart P, Heine A, Paeschke K. Kosiol N, et al. Among authors: brossart p. Mol Cancer. 2021 Feb 25;20(1):40. doi: 10.1186/s12943-021-01328-4. Mol Cancer. 2021. PMID: 33632214 Free PMC article. Review.
Etablierung und Validierung eines didaktischen muskuloskelettalen Ultraschallkurses für Dermatologen unter Verwendung eines innovativen Hand-Ultraschallsystems - die MUDE-Studie (Muskuloskelettaler Ultraschall für Dermatologen).
Grobelski J, Recker F, Wilsmann-Theis D, Hartung W, Karakostas P, Brossart P, Schäfer VS. Grobelski J, et al. Among authors: brossart p. J Dtsch Dermatol Ges. 2021 Dec;19(12):1753-1760. doi: 10.1111/ddg.14614_g. J Dtsch Dermatol Ges. 2021. PMID: 34894194 German.
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F. Platzbecker U, et al. Among authors: brossart p. J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 27400939 Free article. Clinical Trial.
Antitumor immunity and T-cell avidity.
Brossart P. Brossart P. Blood. 2020 Jul 23;136(4):378-380. doi: 10.1182/blood.2020006562. Blood. 2020. PMID: 32702125 Free article. No abstract available.
Early combination therapy of COVID-19 in high-risk patients.
Orth HM, Flasshove C, Berger M, Hattenhauer T, Biederbick KD, Mispelbaum R, Klein U, Stemler J, Fisahn M, Doleschall AD, Baermann BN, Koenigshausen E, Tselikmann O, Killer A, de Angelis C, Gliga S, Stegbauer J, Spuck N, Silling G, Rockstroh JK, Strassburg CP, Brossart P, Panse JP, Jensen BO, Luedde T, Boesecke C, Heine A, Cornely OA, Monin MB. Orth HM, et al. Among authors: brossart p. Infection. 2023 Nov 29. doi: 10.1007/s15010-023-02125-5. Online ahead of print. Infection. 2023. PMID: 38017344
Novel treatment concepts for graft-versus-host disease.
Wolf D, von Lilienfeld-Toal M, Wolf AM, Schleuning M, von Bergwelt-Baildon M, Held SA, Brossart P. Wolf D, et al. Among authors: brossart p. Blood. 2012 Jan 5;119(1):16-25. doi: 10.1182/blood-2011-08-339465. Epub 2011 Sep 26. Blood. 2012. PMID: 21948301 Free article. Review.
258 results